A. Shah's Profile

Role	Title	Level	Year	L/R
🐜	The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial 13 auth. S. Solomon, M. Zile, B. Pieske, A. Voors, A. Shah, E. Kraigher‐Krainer, V. Shi, T. Bransford, M. Takeuchi, J. Gong, ... M. Lefkowitz, M. Packer, J. McMurray	9	2012	9 🐜
🐜	Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis 35 auth. M. Benson, M. Waddington-Cruz, J. Berk, M. Polydefkis, P. Dyck, Annabel K. Wang, V. Planté-Bordeneuve, F. Barroso, G. Merlini, L. Obici, M. Scheinberg, T. Brannagan, W. Litchy, C. Whelan, B. Drachman, ... D. Adams, S. Heitner, I. Conceição, H. Schmidt, G. Vita, J. Campistol, J. Gámez, P. Gorevic, E. Gane, A. Shah, S. Solomon, B. Monia, S. Hughes, J. Kwoh, B. McEvoy, Shiangtung W. Jung, B. Baker, E. Ackermann, M. Gertz, T. Coelho	9	2018	9 🐜
🐜	Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. 12 auth. E. Kraigher‐Krainer, A. Shah, D. Gupta, A. Santos, B. Claggett, B. Pieske, ... M. Zile, A. Voors, M. Lefkowitz, M. Packer, J. McMurray, S. Solomon	9	2014	9 🐜
🐜	Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. 22 auth. R. Thadhani, E. Appelbaum, Y. Pritchett, Yuchiao Chang, J. Wenger, Hector Tamez, I. Bhan, R. Agarwal, C. Zoccali, C. Wanner, ... D. Lloyd‐Jones, Jorge Cannata, B. Thompson, D. Andress, Wuyan Zhang, David Packham, Bhupinder Singh, D. Zehnder, A. Shah, Ajay R Pachika, Warren J. Manning, Scott D. Solomon	9	2012	9 🐜
🐬	Heart Failure With Preserved Ejection Fraction In Perspective. M. Pfeffer, A. Shah, B. Borlaug	9	2019	9 🐬
🐜	Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis 10 auth. S. Seidelmann, Brian Claggett, Susan Cheng, M. Henglin, A. Shah, L. Steffen, ... A. Folsom, E. Rimm, W. Willett, S. Solomon	9	2018	9 🐜
🐜	Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction 11 auth. V. Taqueti, S. Solomon, A. Shah, Akshay S. Desai, J. Groarke, M. Osborne, ... J. Hainer, C. Bibbo, S. Dorbala, R. Blankstein, M. D. Di Carli	8	2018	8 🐜
🦁	Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone 9 auth. A. Shah, B. Claggett, N. Sweitzer, Sanjiv J. Shah, I. Anand, Li Liu, ... B. Pitt, M. Pfeffer, S. Solomon	8	2015	8 🦁
🦁	Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial 13 auth. A. Shah, Sanjiv J. Shah, I. Anand, N. Sweitzer, E. O’Meara, J. Heitner, G. Sopko, Guichu Li, S. Assmann, S. Mckinlay, ... B. Pitt, M. Pfeffer, S. Solomon	8	2014	8 🦁
🐜	Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy 9 auth. S. Solomon, E. Foster, Mikhail Bourgoun, A. Shah, Esperanza Viloria, Mary W. Brown, ... W. Hall, M. Pfeffer, A. Moss	8	2010	8 🐜
🐜	Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial 14 auth. T. Siminiak, Justina C. Wu, M. Haude, U. Hoppe, J. Sadowski, J. Lipiecki, J. Fajadet, A. Shah, T. Feldman, D. Kaye, ... S. Goldberg, W. Levy, S. Solomon, D. Reuter	8	2012	8 🐜
🐜	Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study 8 auth. T. Biering-Sørensen, S. Biering-Sørensen, F. Olsen, M. Sengeløv, P. Jørgensen, R. Møgelvang, ... A. Shah, J. Jensen	8	2017	8 🐜